Znanstveni rad - Izvorni znanstveni rad
Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?
Frontiers in Immunology, 13 (2022); 816159. https://doi.org/10.3389/fimmu.2022.816159


Povezani objekti
COVID-19 | Virtualna zbirka
Citirajte ovaj rad

Ravlić, S., Hećimović, A., Kurtović, T., Ivančić Jelečki, J., Forčić, D., Slović, A. ... Halassy, B. (2022). Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?. Frontiers in Immunology, 13.. doi: 10.3389/fimmu.2022.816159

Ravlić, Sanda, et al. "Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?." Frontiers in Immunology, vol. 13, 2022. https://doi.org/10.3389/fimmu.2022.816159

Ravlić, Sanda, Ana Hećimović, Tihana Kurtović, Jelena Ivančić Jelečki, Dubravko Forčić, Anamarija Slović, Ivan Christian Kurolt, et al. "Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?." Frontiers in Immunology 13 (2022). https://doi.org/10.3389/fimmu.2022.816159

Ravlić, S., et al. (2022) 'Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?', Frontiers in Immunology, 13. doi: 10.3389/fimmu.2022.816159

Ravlić S, Hećimović A, Kurtović T, Ivančić Jelečki J, Forčić D, Slović A, i sur.. Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?. Frontiers in Immunology [Internet]. 2022. [pristupljeno 27.05.2024.];13. doi: 10.3389/fimmu.2022.816159

S. Ravlić, et al., "Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?", Frontiers in Immunology, vol. 13, 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:917926. [Citirano: 27.05.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.